Klebsiella pneumoniae is emerging as an important nosocomial pathogen due to its rapidly increasing multidrug resistance, which has led to a renewed interest in polymyxin antibiotics, such as colistin, as antibiotics of last resort. However, heteroresistance (i.e., the presence of a subpopulation of resistant bacteria in an otherwise susceptible culture) may hamper the effectiveness of colistin treatment in patients. In a previous study, we showed that colistin resistance among extended-spectrum-beta-lactamase (ESBL)-producing K. pneumoniae isolates emerged after the introduction of selective digestive tract decontamination (SDD) in an intensive care unit (ICU). In this study, we investigated heteroresistance to colistin among ESBL-producin...
The emergence and dissemination of carbapenem-resistant Klebsiella pneumoniae (KP), one of the carba...
The emergence of genetic mutations in chromosomal genes and the transmissible plasmid-mediated colis...
Carbapenemase-producing Enterobacteriaceae (CPE) are emerging worldwide, limiting therapeutic option...
The spread of multidrug-resistant (MDR) K. pneumoniae carbapenemase-producing bacteria (KPC) is one ...
The spread of multidrug-resistant (MDR) K. pneumoniae carbapenemase-producing bacteria (KPC) is one ...
BackgroundOver the last two decades, the prevalence of colistin resistance among the members of Ente...
The spread of multidrug-resistant (MDR) K. pneumoniae carbapenemase-producing bacteria (KPC) is one ...
The spread of multidrug-resistant (MDR) K. pneumoniae carbapenemase-producing bacteria (KPC) is one ...
Colistin remains one of the few antibiotics effective against multi-drug resistant (MDR) hospital pa...
The emergence of multidrug-resistant (MDR) Klebsiella pneumoniae has resulted in a more frequent rel...
Colistin remains one of the few antibiotics effective against multi-drug resistant (MDR) hospital pa...
The emergence of carbapenemase-producing Klebsiella pneumoniae strains has triggered the use of old ...
International audienceHeteroresistance to colistin can be defined as the presence of resistant subpo...
Colistin remains one of the few antibiotics effective against multi-drug resistant (MDR) hospital pa...
The appearance of carbapenem-resistant Klebsiella pneumoniae has increased the use of colistin as a ...
The emergence and dissemination of carbapenem-resistant Klebsiella pneumoniae (KP), one of the carba...
The emergence of genetic mutations in chromosomal genes and the transmissible plasmid-mediated colis...
Carbapenemase-producing Enterobacteriaceae (CPE) are emerging worldwide, limiting therapeutic option...
The spread of multidrug-resistant (MDR) K. pneumoniae carbapenemase-producing bacteria (KPC) is one ...
The spread of multidrug-resistant (MDR) K. pneumoniae carbapenemase-producing bacteria (KPC) is one ...
BackgroundOver the last two decades, the prevalence of colistin resistance among the members of Ente...
The spread of multidrug-resistant (MDR) K. pneumoniae carbapenemase-producing bacteria (KPC) is one ...
The spread of multidrug-resistant (MDR) K. pneumoniae carbapenemase-producing bacteria (KPC) is one ...
Colistin remains one of the few antibiotics effective against multi-drug resistant (MDR) hospital pa...
The emergence of multidrug-resistant (MDR) Klebsiella pneumoniae has resulted in a more frequent rel...
Colistin remains one of the few antibiotics effective against multi-drug resistant (MDR) hospital pa...
The emergence of carbapenemase-producing Klebsiella pneumoniae strains has triggered the use of old ...
International audienceHeteroresistance to colistin can be defined as the presence of resistant subpo...
Colistin remains one of the few antibiotics effective against multi-drug resistant (MDR) hospital pa...
The appearance of carbapenem-resistant Klebsiella pneumoniae has increased the use of colistin as a ...
The emergence and dissemination of carbapenem-resistant Klebsiella pneumoniae (KP), one of the carba...
The emergence of genetic mutations in chromosomal genes and the transmissible plasmid-mediated colis...
Carbapenemase-producing Enterobacteriaceae (CPE) are emerging worldwide, limiting therapeutic option...